Product Description :

Issue :

The Saudi Food and Drug Authority (SFDA) has issued a recall of one batch of DoxyPure 100MG Inj. due to the product incompliance with the requirements of the executive regulations for the Pharmaceutical establishments system.

Recommendations :

For healthcare professionals: Stop dispensing the affected batch immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.

For patients,

1. Consult your healthcare provider prior to discontinuing use of the affected batch, or for any health concerns.
2. Contact the recalling firm or SFDA if you have any questions about the recall.
3. Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).